Global Hemodynamic Monitoring Market 2023-2030

Global Hemodynamic Monitoring Market 2023-2030

Global Hemodynamic Monitoring Market Size, Share & Trends Analysis Report by System (Minimally Invasive Monitoring Systems, Invasive Monitoring Systems, Non-invasive Monitoring Systems, and others), by Product (Disposables and Monitors), and by End-User (Hospitals, Clinics & Ambulatory Care Centers, Ambulatory Care Centers, Home Care Settings, and Others), Forecast Period (2023-2030)

The global hemodynamic monitoring market is anticipated to grow at a CAGR of 5.2% during the forecast period (2023-2030). The market’s growth is attributed to the increasing healthcare expenditure. Growing investments in healthcare infrastructure and technologies help to propel the hemodynamic monitoring industry forward. According to the MDPI (Publisher of Open Access Journals), published a report in February 2023, which states that hemodynamic monitoring has seen a great deal of development, though there are still some issues owing to the limited amount of data available for diagnosis and treatment. Furthermore, there is some debate over what is considered a “healthy” blood pressure (BP) range, and recent findings suggest that a 65-mmHg mean arterial pressure (MAP) threshold should be regarded as an absolute minimum to prevent hypotensive conditions. However, this contradicts the movement towards personalized BP thresholds in fluid/vasopressor therapy protocols. Additionally, microcirculatory function has been found to be dissociated in cases of sepsis, though monitoring the microcirculation is still a tedious process. Furthermore, there is a need for earlier detection of deterioration in low-acuity settings, with 4.2 million cases of patient mortality within 30 days after surgery globally each year owing to insufficient ward monitoring. Existing ward measurements still have a false alarm rate of 90%. This further emphasizes the need for managing hemodynamically unstable patients with limited information.

Segmental Outlook

The global hemodynamic monitoring market is segmented based on the system, product, and end-user. Based on the system, the market is sub-segmented into minimally invasive monitoring systems, invasive monitoring systems, non-invasive monitoring systems, and others. Based on the product, the market is sub-segmented into disposables and monitors. Further, based on the end-user, the market is sub-segmented into hospitals, clinics & ambulatory care centers, ambulatory care centers, home care settings, and others. Among the product, monitors sub-segment is expected to capture a significant portion of the market share. This is attributed to the increasing investment by major manufacturers in developing patient-centric care and releasing technologically improved products to market is driving the demand for hemodynamic monitors.

The Non-invasive Monitoring Systems Sub-Segment is Anticipated to Hold a Considerable Share of the global Hemodynamic Monitoring Market

Among the system, the non-invasive monitoring systems sub-segment is expected to hold a considerable share of the global hemodynamic monitoring market. The segmental growth is attributed to technology and methods used across the globe. Non-invasive monitoring systems encompass various technologies such as impedance cardiograph, echocardiography, and pulse contour analysis. Each method has advantages and disadvantages. For instance, they offer ease of use and reduced patient distress, cannot be as precise as invasive methods like thermodilution, particularly in cases of impaired cardiovascular function. According to the National Institute of Health (gov.), in October 2021, a study of 84 heart failure patients was conducted to assess the accuracy of non-invasive hemodynamic monitoring techniques. The majority of patients were NYHA III and IV with a mean ejection fraction of 27%. The results showed that the non-invasive measurements of cardiac output were not as precise as the thermodilution method, that was found to be overestimating. This result is consistent with other studies which have shown that non-invasive hemodynamic monitoring methods are less accurate in cases of decreased cardiac output and increased peripheral vascular resistance. These insights might help explain why there is inaccuracy in measurements of patients in critical condition admitted in intensive care units.

Regional Outlook

The global hemodynamic monitoring market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, North America is anticipated to hold a prominent share of the market across the globe, owing to the increasing aging population in the US suffering from chronic diseases, in addition to the increased usage of hemodynamic monitoring systems in ICUs and emergency rooms, are driving North American market growth.

The Asia-Pacific Region is Expected to Grow at a Significant CAGR in the Global Hemodynamic Monitoring Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the rising advancements in algorithms and data analytics across the region. Algorithm innovations, such as individuals highlighted by Mostcare Up, demonstrate the value of data analytics in hemodynamic monitoring. The pattern is expected to continue, with an emphasis on more complex and precise analytical methods. For instance, in April 2023, Vygon India, launched advanced hemodynamic monitoring system, Mostcare Up, in North India during a Society of Critical Care Medicine (ISCCM) symposium. Mostcare Up is a minimally invasive arterial pressure monitor that is powered by a patented algorithm based on the Pressure Recording Analytical Method (PRAM). It is the only monitor capable of monitoring even minor hemodynamic variations in real time and from beat to beat.

Market Players Outlook

The major companies serving the global hemodynamic monitoring market include Deltex Medical Ltd., Dräger, Edwards Lifesciences Corp., GE HealthCare Technologies Inc., Getinge AB and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2022, Sensydia, launched Cardiac Performance System (CPSTM) has been granted Breakthrough Device Designation by the US Food and Drug Administration (FDA). As part of its Breakthrough Device Designation, the FDA intends to work closely with Sensydia to expedite CPS development and prioritize the assessment of subsequent regulatory submissions.

The Report Covers

Market value data analysis of 2022 and forecast to 2030.

Annualized market revenues ($ million) for each market segment.

Country-wise analysis of major geographical regions.

Key companies operating in the global hemodynamic monitoring market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.

Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.

Analysis of market-entry and market expansion strategies. Competitive strategies by identifying ‘who-stands-where’ in the market.